- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07650981
Multimodal Mechanical, Tissue, Architectural, and Histological Evaluation of the Bone and Sutures of the Parietal Bone in an Infant With Craniosynostosis. (CRANIOMECA)
10. Juni 2026 aktualisiert von: Hospices Civils de Lyon
The human skull is a complex structure that protects the underlying tissues, including the brain.
Certain rare conditions and diseases, such as craniosynostosis-which affects 1 in 2,000 to 2,500 children-impair these functions and lead to increased intracranial pressure, posing a neurological risk.
The most common form of craniosynostosis is scaphocephaly (50%), which manifests as premature closure of the sagittal suture, halting growth at that site and causing an abnormal skull shape and altered local biomechanical properties.
The parietal bone is a flat, regular bone that embryologically originates from the neurocranium.
Its characteristics vary according to age, sex, and morphotype.
Studies on the multimodal characterization of the properties of growing cortical bone focus on the characterization of growing fibulae and femurs.
A comparison was made with adult bone, allowing for the establishment of specific pediatric characteristics.
The mechanical, morphological, architectural, and tissue properties of the skull vary considerably between adults and children.
They are uniquely adapted to the rapid growth and development of the brain.
The analysis of the mechanical, architectural, and tissue properties of the parietal bone in infants involves evaluating its ability to resist applied forces and stresses, analyze its shape, composition, and the quality of the bone tissue itself, including aspects such as mineralization, collagen fiber structure, and bone mineral density.
A study conducted on samples obtained from parietal resections in infants operated on for scaphocephaly evaluated the microstructural and mechanical characteristics of this region of the skull vault, allowing for the determination of mechanical and morphological characteristics.
However, the samples were located near the stenosis, with the sampling site determined macroscopically by the surgeon.
The characteristics of the parietal bone in infants with scaphocephaly were also evaluated and show properties correlated with the degree of ossification regardless of age.
However, the available data have a significant limitation: existing characterizations are based on pathological samples taken near the stenotic area, or on models of growing long bones that do not reflect the specific characteristics of the cranial vault.
To date, there is no certainty regarding the mechanical, architectural, and tissue properties of the parietal bone considered healthy regardless of craniosynostosis in infants, taking into account the developmental constraints specific to the first months of life.
These properties are, however, strongly influenced by the compressive forces experienced during birth and then by the gradual changes in gravitational and postural forces associated with motor development (head control, sitting, crawling, and walking on all fours).
These data could help improve our understanding of normal cranial physiology and its variations in the presence of pathology.
The primary objective is to describe the mechanical, architectural, tissue, and histological properties of the parietal bone in infants with craniosynostosis.
To evaluate ex vivo, both near and far from the stenosis, the mechanical, architectural, tissue, and histological properties of the parietal bone and sutures in infants aged 3 to 12 months with craniosynostosis.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Intervention / Behandlung
Studientyp
Beobachtungs
Einschreibung (Geschätzt)
80
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Federico DI ROCCO, Pr
- Telefonnummer: +33 04 72 35 75 72
- E-Mail: federico.dirocco@chu-lyon.fr
Studienorte
-
-
Rhone
-
Bron, Rhone, Frankreich, 69500
- Hopital Femme MèreEnfant / Hospices Civils de Lyon
-
Kontakt:
- Federico DI ROCCO, Pr
- Telefonnummer: +33 04 72 35 75 72
- E-Mail: federico.dirocco@chu-lyon.fr
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
Akzeptiert gesunde Freiwillige
N/A
Probenahmeverfahren
Nicht-Wahrscheinlichkeitsprobe
Studienpopulation
80 Infants aged 3 to 12 months requiring craniostenosis surgery and care at the Women's and Children's Hospital (HFME) in the pediatric neurosurgery department
Beschreibung
Inclusion Criteria:
- Patients diagnosed with craniosynostosis by a pediatric neurosurgeon.
- Patients treated in the neurosurgery department of Prof. Federico Di Rocco at the Hôpital Femme Mère Enfant.
- Patients aged 3 to 12 months.
Exclusion Criteria:
- Positional cranial deformities
- History of previous cranial surgery in the parietal region (including osteotomies, implant placement, or cranioplasty).
- Recent significant head trauma (< 6 months) involving the cranial vault.
- Documented metabolic bone disease (e.g., osteogenesis imperfecta, uncorrected clinical or biochemical rickets).
- Severe systemic disease likely to alter bone metabolism (e.g., advanced chronic kidney disease, severe liver disease, uncontrolled endocrine disorders).
- Pharmacological treatment likely to significantly alter bone composition/biomechanics within the last 6 months (e.g., prolonged systemic corticosteroids, bisphosphonates, other antiresorptive agents, chemotherapy).
- Refusal by parents/guardians to participate
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Patients with craniostenosis diagnosed
This study focuses on infants aged 3 to 12 months who require craniostenosis surgery and are treated at the Hôpital Femme Mère Enfant (HFME) in the pediatric neurosurgery department.
|
In conventional surgery, bone fragments and sutures are removed; the number of these may vary depending on the surgeon's assessment, as well as the location, shape, and surface area, which differ from patient to patient.
Some of these fragments, classified as surgical waste and intended for disposal, will be retained for study.
A urine sample of approximately 5 mL will be collected directly from the catheter bag; the urine is also considered surgical waste.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Describe , echanical properties, tissue properties, architectural properties, histomorphometry of the parietal bone.
Zeitfenster: Within 3 months
|
Within 3 months
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
1. September 2026
Primärer Abschluss (Geschätzt)
1. September 2028
Studienabschluss (Geschätzt)
1. September 2028
Studienanmeldedaten
Zuerst eingereicht
4. Juni 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
10. Juni 2026
Zuerst gepostet (Tatsächlich)
16. Juni 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
16. Juni 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
10. Juni 2026
Zuletzt verifiziert
1. Juni 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 69HCL26_0344
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .